David S. Peterseim
Duke University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David S. Peterseim.
The Journal of Thoracic and Cardiovascular Surgery | 1999
David S. Peterseim; Ye-Ying Cen; Srinivas Cheruvu; Kevin P. Landolfo; Thomas M. Bashore; James E. Lowe; Walter G. Wolfe; Donald D. Glower
OBJECTIVE The purpose of this study was to optimize selection criteria of biologic versus mechanical valve prostheses for aortic valve replacement. METHODS Retrospective analysis was performed for 841 patients undergoing isolated, first-time aortic valve replacement with Carpentier-Edwards (n = 429) or St Jude Medical (n = 412) prostheses. RESULTS Patients with Carpentier-Edwards and St Jude Medical valves had similar characteristics. Ten-year survival was similar in each group (Carpentier-Edwards 54% 3% versus St Jude Medical 50% 6%; P =.4). Independent predictors of worse survival were older age, renal or lung disease, ejection fraction less than 40%, diabetes, and coronary disease. Carpentier-Edwards versus St Jude Medical prostheses did not affect survival (P =.4). Independent predictors of aortic valve reoperation were younger age and Carpentier-Edwards prosthesis. The linearized rates of thromboembolism were similar, but the linearized rate of hemorrhage was lower with Carpentier-Edwards prostheses (P <.01). Perivalvular leak within 6 months of operation was more likely with St Jude Medical than with Carpentier-Edwards prostheses (P =.02). Estimated 10-year survival free from valve-related morbidity was better for the St Jude Medical valve in patients aged less than 65 years and was better for the Carpentier-Edwards valve in patients aged more than 65 years. Patients with renal disease, lung disease (in patients more than age 60 years), ejection fraction less than 40%, or coronary disease had a life expectancy of less than 10 years. CONCLUSIONS For first-time, isolated aortic valve replacement, mechanical prostheses should be considered in patients under age 65 years with a life expectancy of at least 10 years. Bioprostheses should be considered in patients over age 65 years or with lung disease (in patients over age 60 years), renal disease, coronary disease, ejection fraction less than 40%, or a life expectancy less than 10 years.
European Journal of Cardio-Thoracic Surgery | 1997
Simon W.H. Kendall; Hartmuth B. Bittner; David S. Peterseim; Kurt A. Campbell; P. Van Trigt
OBJECTIVES Early morbidity and mortality post cardiac transplantation is frequently caused by right ventricular failure; this is usually attributed to an elevated pulmonary vascular resistance in the recipient. Brain death in the donor is recognised as causing left ventricular dysfunction, but its effects on the right ventricle have not previously been studied. The aim of this study was to investigate right ventricular function following brain death, using a canine model. METHODS The hearts of 33 dogs were instrumented with micromanometers, flow probes and dimension transducers to measure minor/major axes, and right and left ventricular free wall to septal distances. Left ventricular volume was calculated according to the prolate ellipsoid model and right ventricular volume was calculated according to the shell subtraction method. Systolic function for left and right ventricles was analysed by plotting ventricular stroke work vs. end-diastolic volume during a caval occlusion (preload-independent recruitable stroke work PRSW). Brain death was instigated by inflation of a subdurally placed intracranial balloon; subsequently blood pressure was maintained with intravenous fluid whilst no inotropic medications were given. Data were collected at baseline, and at 2 and 4 h thereafter. A two-tailed paired Students t-test was applied to compare post-brain death data with baseline measurements. RESULTS All animals had an initial hyperdynamic response post brain death ensued by the development of diabetes insipidus. Brain stem death was validated by neuropathological examination at the termination of the experiments. Right and left ventricular systolic function had deteriorated significantly 2 h post brain death by 34.4% (+/- 5.1%, P < 0.001) and 20.4% (+/- 3.4%, P < 0.001), respectively, from baseline PRSW [RV = 23.6 erg.10(3) (+/- 1.5), LV = 76.2 erg.10(3) (+/- 3.5)]. This deterioration remained at 4 h post brain death (29.4% (+/- 4.9%, P < 0.001) and 21.2% (+/- 4.3%, P < 0.001), respectively). (The results are expressed as mean and S.E.M.). CONCLUSIONS Brain death causes a significant decrease in left and right ventricular function. The injury to the right ventricle is more prominent than the left ventricle, and at 2 h post brain death it is significantly greater. Failure of the right ventricle post transplantation in clinical practice may be related to this brain death induced injury. Further studies are required to investigate the mechanisms of this injury.
Journal of Heart and Lung Transplantation | 1993
Cary H. Meyers; Thomas A. D'Amico; David S. Peterseim; A. M. Jayawant; Charles Steenbergen; David C. Sabiston; P. Van Trigt; J. Young; T. Egan; P. McKeown
Journal of Heart and Lung Transplantation | 1995
David S. Peterseim; Theodore N. Pappas; Cary H. Meyers; G. S. Shaeffer; William C. Meyers; P. Van Trigt
American Journal of Surgery | 1996
William C. Meyers; David S. Peterseim; Theodore N. Pappas; Philip R. Schauer; Steven Eubanks; Elizabeth A. Murray; Paul V. Suhocki
Journal of Surgical Research | 1996
Hartmuth B. Bittner; Edward P. Chen; David S. Peterseim; Peter Van Trigt
Journal of Heart and Lung Transplantation | 1994
David S. Peterseim; L C Chesnut; Cary H. Meyers; Thomas A. D'Amico; P. Van Trigt; Debra A. Schwinn
Journal of Surgical Research | 1993
Cary H. Meyers; Thomas A. D'Amico; David S. Peterseim; Rakesh Uppal; Cemil M. Purut; Peter K. Smith; David C. Sabiston; Peter Van Trigt
Journal of Surgical Research | 1993
David S. Peterseim; Cary H. Meyers; Damian M. Craig; Jeff S. Heinle; A.Mark Jayawant; John J. Devaney; Bruce Klitzman; Peter Van Trigt
Journal of Heart and Lung Transplantation | 1993
David S. Peterseim; Cary H. Meyers; Craig Dm; Davis Jw; Campbell Ka; D'Amico Ta; Van Trigt P